{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:56:22Z","timestamp":1781240182987,"version":"3.54.1"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Despite major advances in reperfusion therapy and pharmacological management, acute myocardial infarction (AMI) remains one of the leading causes of mortality and morbidity worldwide. Conventional treatment strategies primarily focus on restoring coronary blood flow to ischemic myocardium; however, their ability to regenerate damaged cardiac tissue remains limited. In recent years, exosomes have emerged as a promising cell-free therapeutic approach for cardiac repair following AMI. Exosomes are nanosized extracellular vesicles secreted by various cell types that carry diverse bioactive molecules, including microRNAs, proteins, lipids, and signaling factors, which mediate intercellular communication and regulate multiple biological processes involved in myocardial healing. Emerging experimental and preclinical evidence suggests that exosome-based therapy may attenuate inflammation, reduce cardiomyocyte apoptosis, enhance angiogenesis, modulate immune responses, and promote myocardial regeneration following ischemic injury. Compared with conventional stem cell therapy, exosomes offer several advantages, including lower immunogenicity, reduced risk of tumorigenicity, improved stability, and easier storage and handling. Furthermore, engineered exosomes and targeted delivery systems are being investigated to enhance therapeutic specificity and efficacy in cardiovascular diseases. In addition to their therapeutic potential, circulating exosomes are also being explored as diagnostic and prognostic biomarkers for the early detection and monitoring of AMI. This review highlights the biological characteristics of exosomes, their mechanisms of action in myocardial repair, current experimental and clinical evidence, and future perspectives of exosome-based therapeutics in the management of AMI.<\/jats:p>","DOI":"10.1097\/crd.0000000000001365","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:00:44Z","timestamp":1781236844000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exosome Therapy: A Novel Investigational Approach in Acute Myocardial Infarction"],"prefix":"10.1097","author":[{"given":"Aparna","family":"Joshi","sequence":"first","affiliation":[{"name":"Department of Anatomy, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Anatomy, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsering","family":"Sangdup","sequence":"additional","affiliation":[{"name":"Department of CTVS, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Jacob","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Anatomy, PGIMER, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"R1-20260612","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India: current epidemiology and future directions.","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"key":"R2-20260612","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990\u20132016.","volume":"6","author":"Prabhakaran","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R3-20260612","doi-asserted-by":"crossref","first-page":"100156","DOI":"10.1016\/j.lansea.2023.100156","article-title":"The burgeoning cardiovascular disease epidemic in Indians\u2014perspectives on contextual factors and potential solutions.","volume":"12","author":"Kalra","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"R5-20260612","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R6-20260612","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"R7-20260612","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1161\/CIRCULATIONAHA.108.793745","article-title":"Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.","volume":"119","author":"Huynh","year":"2009","journal-title":"Circulation"},{"key":"R8-20260612","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5455\/medarh.2017.71.183-187","article-title":"Experience and outcomes of primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction of tertiary care center in Bosnia and Herzegovina.","volume":"71","author":"Jahic","year":"2017","journal-title":"Med Arch"},{"key":"R9-20260612","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"R10-20260612","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction.","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-20260612","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"R12-20260612","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcin.2012.10.020","article-title":"A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction.","volume":"6","author":"Vis","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R13-20260612","article-title":"Optimal timing of surgical revascularization in patients with acute myocardial infarction.","volume":"7","author":"Zahrai","year":"2023","journal-title":"Vessel Plus"},{"key":"R14-20260612","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/eurheartj\/ehw113","article-title":"Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.","volume":"37","author":"Madonna","year":"2016","journal-title":"Eur Heart J"},{"key":"R15-20260612","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2016.2225","article-title":"Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review.","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R16-20260612","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration\u2014lessons learned and future directions.","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R17-20260612","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","article-title":"Cardiomyocyte regeneration: a consensus statement.","volume":"136","author":"Eschenhagen","year":"2017","journal-title":"Circulation"},{"key":"R18-20260612","doi-asserted-by":"crossref","first-page":"636136","DOI":"10.3389\/fcell.2021.636136","article-title":"The current dilemma and breakthrough of stem cell therapy in ischemic heart disease.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R19-20260612","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","article-title":"Paracrine mechanisms of mesenchymal stem cells in tissue repair.","author":"Gnecchi","year":"2016","journal-title":"Methods Mol Biol"},{"key":"R20-20260612","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"R21-20260612","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1152\/physrev.00021.2014","article-title":"Cardiac regeneration and stem cells.","volume":"95","author":"Zhang","year":"2015","journal-title":"Physiol Rev"},{"key":"R22-20260612","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","article-title":"Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.","volume":"116","author":"Gy\u00f6ngy\u00f6si","year":"2015","journal-title":"Circ Res"},{"key":"R23-20260612","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced pluripotent stem cells 10 years later: for cardiac applications.","volume":"120","author":"Yoshida","year":"2017","journal-title":"Circ Res"},{"key":"R24-20260612","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2012.10.052","article-title":"Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains.","volume":"61","author":"Tseliou","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R25-20260612","doi-asserted-by":"crossref","first-page":"165489","DOI":"10.1016\/j.bbadis.2019.06.003","article-title":"Stem cell therapy in heart failure: where do we stand today?","volume":"1866","author":"Nair","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R26-20260612","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes.","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"R27-20260612","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1194\/jlr.R083725","article-title":"A new role for extracellular vesicles: how small vesicles can feed tumors\u2019 big appetite.","volume":"59","author":"Lazar","year":"2018","journal-title":"J Lipid Res"},{"key":"R28-20260612","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","article-title":"Clinical applications of stem cell-derived exosomes.","volume":"9","author":"Tan","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R29-20260612","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"R30-20260612","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","article-title":"Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity.","volume":"109","author":"Sahoo","year":"2011","journal-title":"Circ Res"},{"key":"R31-20260612","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"R32-20260612","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions.","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R33-20260612","article-title":"Engineered cells for cardiovascular diseases.","author":"Zhou","year":"2025","journal-title":"Cell Biomaterials"},{"key":"R34-20260612","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200911018","article-title":"Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A\u2013C.","volume":"189","author":"Hsu","year":"2010","journal-title":"J Cell Biol"},{"key":"R35-20260612","doi-asserted-by":"crossref","first-page":"24641","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake.","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"R36-20260612","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis.","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"R37-20260612","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends.","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"R38-20260612","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R39-20260612","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis.","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"R40-20260612","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis.","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R41-20260612","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/cells11020186","article-title":"Methodologies to isolate and purify clinical grade extracellular vesicles for medical applications.","volume":"11","author":"Akbar","year":"2022","journal-title":"Cells"},{"key":"R42-20260612","doi-asserted-by":"crossref","first-page":"102121","DOI":"10.1016\/j.tranon.2024.102121","article-title":"A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications.","volume":"50","author":"Dilsiz","year":"2024","journal-title":"Transl Oncol"},{"key":"R43-20260612","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1074\/mcp.M900152-MCP200","article-title":"Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature.","volume":"9","author":"Mathivanan","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"R44-20260612","doi-asserted-by":"crossref","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.","volume":"4","author":"Wiklander","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R45-20260612","doi-asserted-by":"crossref","first-page":"e020402","DOI":"10.1161\/JAHA.120.020402","article-title":"All roads lead to Rome (the heart): cell retention and outcomes from various delivery routes of cell therapy products to the heart.","volume":"10","author":"Li","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R46-20260612","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/eurheartj\/ehae089","article-title":"Injury minimization after myocardial infarction: focus on extracellular vesicles.","volume":"45","author":"Barile","year":"2024","journal-title":"Eur Heart J"},{"key":"R47-20260612","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","article-title":"Exosomes and cardiac repair after myocardial infarction.","volume":"114","author":"Sahoo","year":"2014","journal-title":"Circ Res"},{"key":"R48-20260612","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/stem.3456","article-title":"Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases.","volume":"39","author":"Herman","year":"2021","journal-title":"Stem Cells"},{"key":"R49-20260612","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCULATIONAHA.123.065005","article-title":"Inhalable stem cell exosomes promote heart repair after myocardial infarction.","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"R50-20260612","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13205-023-03521-2","article-title":"Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives.","volume":"13","author":"Sen","year":"2023","journal-title":"3 Biotech"},{"key":"R51-20260612","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4070\/kcj.2025.0022","article-title":"Exosome-based therapy in cardiovascular diseases: a new frontier in cardiovascular disease treatment.","volume":"55","author":"Chae","year":"2025","journal-title":"Korean Circ J"},{"key":"R52-20260612","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.vesic.2025.100073","article-title":"The mechanisms and application prospects of exosomes in acute myocardial infarction.","volume":"5","author":"Zhou","year":"2025","journal-title":"Extracell Vesicle"},{"key":"R53-20260612","doi-asserted-by":"crossref","first-page":"e2101058","DOI":"10.1002\/advs.202101058","article-title":"Enhanced delivery of neuroactive drugs via nasal delivery with a self\u2010healing supramolecular gel.","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R54-20260612","doi-asserted-by":"crossref","first-page":"1762630","DOI":"10.3389\/fphar.2026.1762630","article-title":"Mesenchymal stem cell-derived exosomes in myocardial infarction repair: therapeutic potential and scaffold-based delivery strategies.","volume":"17","author":"Azimian Zavareh","year":"2026","journal-title":"Front Pharmacol"},{"key":"R55-20260612","doi-asserted-by":"crossref","first-page":"601990","DOI":"10.3389\/fcvm.2020.601990","article-title":"Systemic mesenchymal stem cell-derived exosomes reduce myocardial infarct size: characterization with MRI in a porcine model.","volume":"7","author":"Charles","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R56-20260612","doi-asserted-by":"crossref","first-page":"eaay1318","DOI":"10.1126\/scitranslmed.aay1318","article-title":"Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine.","volume":"12","author":"Gao","year":"2020","journal-title":"Sci Transl Med"},{"key":"R57-20260612","first-page":"124","article-title":"Exosome-based therapeutics in cardiovascular disease: comprehensive analysis of current developments and future directions.","volume":"15","author":"Elsaka","year":"2025","journal-title":"J Ind Coll Cardiol"},{"key":"R58-20260612","doi-asserted-by":"crossref","first-page":"e008737","DOI":"10.1161\/JAHA.118.008737","article-title":"Engineered exosomes with ischemic myocardium\u2010targeting peptide for targeted therapy in myocardial infarction.","volume":"7","author":"Wang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R59-20260612","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial.","volume":"3","author":"Escudier","year":"2005","journal-title":"J Transl Med"},{"key":"R60-20260612","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.","volume":"3","author":"Morse","year":"2005","journal-title":"J Transl Med"},{"key":"R61-20260612","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19.","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"key":"R62-20260612","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/ten.teb.2022.0118","article-title":"Therapeutic strategies and enhanced production of stem cell-derived exosomes for tissue regeneration.","volume":"29","author":"Kim","year":"2023","journal-title":"Tissue Eng Part B Rev"},{"key":"R63-20260612","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury.","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res"},{"key":"R64-20260612","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction.","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc Res"},{"key":"R65-20260612","doi-asserted-by":"crossref","first-page":"579142","DOI":"10.4061\/2010\/579142","article-title":"Phases I\u2013III clinical trials using adult stem cells.","volume":"2010","author":"Sanz-Ruiz","year":"2010","journal-title":"Stem Cells Int"},{"key":"R66-20260612","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/HCO.0000000000000956","article-title":"Clinical trials of cell therapy for heart failure: recent results warrant continued research.","volume":"37","author":"Bolli","year":"2022","journal-title":"Curr Opin Cardiol"},{"key":"R67-20260612","doi-asserted-by":"crossref","first-page":"106600","DOI":"10.1016\/j.biocel.2024.106600","article-title":"Extracellular vesicles in the diagnosis and treatment of cardiovascular disease. What\u2019s behind? What do we need to implement them into clinical practice?","volume":"172","author":"Nowicka","year":"2024","journal-title":"Int J Biochem Cell Biol"},{"key":"R68-20260612","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/biom15040583","article-title":"Plasma exosomal proteomics identifies differentially expressed proteins as biomarkers for acute myocardial infarction.","volume":"15","author":"Zhou","year":"2025","journal-title":"Biomolecules"},{"key":"R69-20260612","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s44385-025-00030-0","article-title":"Exosomes: bridge metabolic regulation in cardiac repair.","volume":"2","author":"Mao","year":"2025","journal-title":"NPJ Biomed Innov"},{"key":"R70-20260612","doi-asserted-by":"crossref","first-page":"e16268","DOI":"10.1002\/advs.202516268","article-title":"AI\u2010guided SERS defines a pan\u2010cancer diagnostic biomarker.","author":"Zhang","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"R71-20260612","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/biomedicines12071458","article-title":"Innovative semi-nested realtime PCR assay with extendable blocking probe for enhanced analysis of SEPT9 methylation in colorectal cancer.","volume":"12","author":"Duong","year":"2024","journal-title":"Biomedicines"},{"key":"R72-20260612","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/cvr\/cvac031","article-title":"Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.","volume":"119","author":"Davidson","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R73-20260612","doi-asserted-by":"crossref","first-page":"1739907","DOI":"10.3389\/fcvm.2026.1739907","article-title":"Exosome-delivered bioactive molecules regulate macrophage polarization in atherosclerosis and myocardial infarction: mechanisms and therapeutic potential.","volume":"13","author":"Zhou","year":"2026","journal-title":"Front Cardiovasc Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:00:56Z","timestamp":1781236856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001365","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}